Understanding the complex pathogenesis in myocardial ischemia/reperfusion (I/R) injury (IRI) is an urgent problem in clinical trials. Increasing pieces of evidence have suggested that miRNAs are involved in the occurrence and development of heart diseases by regulating mitochondria-related gene expression. Mitochondria have been acknowledged as the key triggers of cardiac I/R injury. However, the potential impact of miR-130a on mitochondria remains unclear in myocardial IRI. Exploring the regulatory mechanism of miR-130a on mitochondria may provide a new target for IRI therapy. In the present study, we found that miR-130a significantly increased in acute myocardial infarction (AMI) patients and myocardial I/R rats. MiR-130a could downregulate the viability of cardiomyocytes and the knockdown of miR-130a could protect the viability of cardiomyocytes under hypoxia-reoxygenation (HR). Over-expression of miR-130a resulted in mitochondrial dysfunction. It was evidenced by decreases in mitochondrial ATP production, mitochondrial membrane potential (MMP), and an increase in reactive oxygen species (ROS) production. However, suppression of miR-130a could protect against mitochondrial damage, show elevation of mitochondrial ATP production rate and MMP, and reduce ROS production. We further explored the effect of miR-130a on the mitochondrial quality control (QMC) system by determining mitochondrial-protein-specific proteases and analyzed mitochondrial morphology by fluorescence imaging and electron microscopy, respectively. It was noted that miR-130a could suppress mitochondrial fusion and FUNDC1-mediated mitophagy to accelerate myocardial IRI. Moreover, we investigated the potential miR-130a targeted mitochondria-related genes to understand the regulatory mechanism of miR-130a in the setting of myocardial IRI. It was revealed that miR-130a targeted GJA1, and GJA1 rescued IRI by enhancing ATP production rate and oxidative phosphorylation, meanwhile protecting cell viability, MMP, and activating mitophagy. In addition, the knockdown of miR-130a significantly activated FUNDC1-mediated mitophagy, while the knockdown of GJA1 reversed the relevant response. Collectively, our findings suggest that miR-130a regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial IRI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968299 | PMC |
| http://dx.doi.org/10.1038/s41420-023-01372-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploiting Mitochondria by Triggering a Faulty Unfolded Protein Response Leads to Effective Cardioprotection.
Int J Med Sci
January 2025
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
This study investigates the role of Fundc1 in cardiac protection under high-altitude hypoxic conditions and elucidates its underlying molecular mechanisms. Using cardiomyocyte-specific knockout ( ) mice, we demonstrated that deficiency exacerbates cardiac dysfunction under simulated high-altitude hypoxia, manifesting as impaired systolic and diastolic function. Mechanistically, we identified that Fundc1 regulates cardiac function through the mitochondrial unfolded protein response (mito-UPR) pathway.
View Article and Find Full Text PDFEndothelial FUNDC1 Deficiency Drives Pulmonary Hypertension.
Circ Res
December 2024
State Key Laboratory of Medicinal Chemistry Biology, Haihe Laboratory of Cell Ecosystem, College of Life Sciences, Nankai University, China. (Y.P., D.R., Y.Y., J.S., Q.A., W.H., X. Luo, C.B., L. Zhu, Q.W., S.L., Y. Zhang, J.L., L.L., H.Z., Y.L., G.C., Q.C., X. Liao).
Background: Pulmonary hypertension (PH) is associated with endothelial dysfunction. However, the cause of endothelial dysfunction and its impact on PH remain incompletely understood. We aimed to investigate whether the hypoxia-inducible FUNDC1 (FUN14 domain-containing 1)-dependent mitophagy pathway underlies PH pathogenesis and progression.
View Article and Find Full Text PDFMultiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease.
Front Cell Dev Biol
October 2024
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Article Synopsis
- - This article discusses the role of a protein called FUNDC1 in mitochondria, particularly in how it regulates mitochondrial autophagy, which is the process of degrading unhealthy mitochondria to maintain cellular health.
- - FUNDC1 activity is influenced by various phosphorylation and dephosphorylation mechanisms involving specific kinases like ULK1, Src, and CK2, which respectively promote or inhibit the mitophagy process.
- - Abnormal FUNDC1 function is linked to several kidney diseases, suggesting that understanding its regulatory mechanisms could help in developing treatments for conditions such as acute kidney injury and chronic kidney disease.
FUNDC1-mediated mitophagy regulates photodamage independently of the PINK1/Parkin-dependent pathway.
Free Radic Biol Med
November 2024
Department of Dermatology, The First Hospital of China Medical University, Shenyang, China; National Joint Engineering Research Center for Theranostics of Immunological Skin Diseases, The First Hospital of China Medical University and Key Laboratory of Immunodermatology, Ministry of Health and Ministry of Education, Shenyang, China; Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address:
Article Synopsis
- UVB exposure induces photodamage in skin, and the study investigates the role of FUNDC1-mediated mitophagy in this process.
- FUNDC1 knockdown reduces mitochondrial damage and cell apoptosis in UVB-treated cells and mice, while overexpression leads to increased cell death.
- The findings suggest that decreased FUNDC1 expression correlates with photodamage in human skin, highlighting its potential as a target for protecting against UVB-induced skin damage.*
Hypoxia-induced mitochondrial fission regulates the fate of bone marrow mesenchymal stem cells by maintaining HIF1α stabilization.
Free Radic Biol Med
November 2024
Department of Orthopedic Surgery of the Second Affiliated Hospital, School of Medicine, Zhejiang University, No. 88, Jiefang Road, Hangzhou, 310009, China; Orthopedics Research Institute of Zhejiang University, No. 88, Jiefang Road, Hangzhou, 310009, China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou City, Zhejiang Province, China. Electronic address:
Article Synopsis
- Controlled low oxygen levels boost the ability of bone marrow mesenchymal stem cells (BMSCs) to turn into bone-forming cells and produce calcium nodules, but the specific processes behind this are not well-understood.
- The study investigates how hypoxia affects BMSCs and highlights the role of FUNDC1, a factor that influences mitochondrial function, particularly during low-oxygen conditions.
- Findings reveal that FUNDC1 promotes bone formation not through mitophagy but by enhancing mitochondrial fission, which helps stabilize a protein called HIF1α, crucial for BMSC differentiation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!